The first major update since 2003 was announced this week during the 2017 American Heart Association Scientific Sessions.
On Monday, the American Heart Association (AHA) and the American College of Cardiology unveiled new clinical guidelines for treating hypertension, marking the first major update since 2003. Hypertension, which occurs when there is too much pressure of blood against the walls of the arteries, is the second leading cause of heart disease after smoking. The new guidelines will have a ripple effect across healthcare, changing treatment protocols, data reporting, and whether practices and health systems are succeeding in population health. Here are 5 things to know about the new hypertension guidelines:
For more from the 2017 American Heart Association Scientific Sessions, visit our conference page at ajmc.com.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Top 5 Most-Read Heart Failure Articles of 2024
December 23rd 2024Some of the top heart failure research looked at statins and semaglutide for heart failure with preserved ejection fraction, diabetes-related heart failure risks, and the protective cardiovascular effects of COVID-19 vaccination.
Read More